FAKTOR-OPTIONSSCHEIN - IPSEN | Market Closed - Börse Stuttgart 11:39:06 28/06/2024 pm IST | ||
| 8.06 EUR | -1.10% |
|
| Current month | +13.52% | ||
| 1 month | +11.79% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 28/24/28 | 8.06 | -1.10% |
| 27/24/27 | 8.15 | +1.75% |
| 26/24/26 | 8.01 | +3.35% |
| 25/24/25 | 7.75 | +0.91% |
| 24/24/24 | 7.68 | -6.34% |
Delayed Quote Börse Stuttgart
Last update June 28, 2024 at 11:39 pm IST
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | Morgan Stanley |
| WKN | MG1K9W |
| ISIN | DE000MG1K9W8 |
| Date issued | 03/04/2024 |
| Strike | 152.1 € |
| Maturity | Unlimited |
| Parity | 4.65 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 11.49 € |
|---|---|
| Lowest since issue | 6.19 € |
| Spread | 0.1 € |
| Spread % | 1.23% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
114.5
EUR
Average target price
127.3
EUR
Spread / Average Target
+11.16%
- Stock Market
- Certificates
- Certificat
